- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 211/64 - Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4 having an aryl radical as the second substituent in position 4
Patent holdings for IPC class C07D 211/64
Total number of patents in this class: 22
10-year publication summary
|
3
|
0
|
2
|
1
|
1
|
3
|
1
|
0
|
5
|
1
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Mayo Foundation for Medical Education and Research | 3386 |
4 |
| F. Hoffmann-La Roche AG | 7816 |
2 |
| Boehringer Ingelheim International GmbH | 4487 |
2 |
| Sumitomo Pharma Co., Ltd. | 555 |
2 |
| Hoffmann-La Roche Inc. | 3804 |
1 |
| The Board of Trustees of the University of Illinois | 2747 |
1 |
| 92229129 Quebec Inc. | 5 |
1 |
| Chugai Seiyaku Kabushiki Kaisha | 1421 |
1 |
| D. E. Shaw Research, LLC | 12 |
1 |
| Industry-Academic Cooperation Foundation, Yonsei University | 2444 |
1 |
| MethylGene Inc. | 32 |
1 |
| 7503547 Canada, Inc. | 5 |
1 |
| Firmenich Incorporated | 157 |
1 |
| sanofi-aventis | 295 |
1 |
| Chengdu MFS Pharma. Co., Ltd. | 17 |
1 |
| Ube Corporation | 453 |
1 |
| Other owners | 0 |